Indian pharma sector set for mixed quarter: Report Ruchika Sharma9 Oct 2024 4:16 PM ISTNew Delhi: The Indian pharmaceutical industry is projected to experience a mixed quarter, with slower growth anticipated in the branded formulations,...
Lupin gets 5 USFDA observations for Pune biotech facility Ruchika Sharma7 Oct 2024 11:30 AM ISTMumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with five observations at...
Lupin arm buys nine brands of Medical Nutritional Institute in South Africa Ruchika Sharma5 Oct 2024 12:30 PM ISTThe acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance.
Lupin, Scope Ophthalmics Ireland ink pact to market Optase range of products in Mexico Ruchika Sharma2 Oct 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has signed a distribution agreement with Scope Ophthalmics Ireland (SCOPE) for the...
USFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility Ruchika Sharma28 Sept 2024 12:15 PM ISTMumbai: Lupin has announced that the United States Food and Drug Administration (USFDA) has issued three observations each on the API and...
Lupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia Ruchika Sharma28 Sept 2024 11:10 AM ISTMumbai: Global pharma major, Lupin Limited has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a distribution agreement...
Lupin bags USFDA nod for Bumetanide Injection for edema treatment Ruchika Sharma19 Sept 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin, Dr Reddy's Labs recall products in US over manufacturing issues: USFDA Ruchika Sharma5 Sept 2024 1:30 PM ISTNew Delhi: Pharma majors Lupin, Dr Reddy's Laboratories are recalling products in the US over manufacturing issues, according to a latest...
Lupin launches Mirabegron Extended-Release Tablets in US Ruchika Sharma4 Sept 2024 8:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, after having...
Lupin unveils generic cancer drug in US Ruchika Sharma30 Aug 2024 1:00 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50...
USFDA nod to Lupin Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma28 Aug 2024 1:30 PM ISTBrimonidine Tartrate Ophthalmic Solution, 0.1% indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma.
Lupin bags Health Canada nod for biosimilar Pegfilgrastim Ruchika Sharma25 Aug 2024 2:00 PM ISTArmlupeg is available in a form of pre-filled syringe of 6mg/0.6 ml.
